SUSAN BALMER: Open Payments
NPI 1164640058 · MARQUETTE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$493 in 26 payments from 9 companies in 2025. Trend: 2023 $322 · 2024 $261 · 2025 $493
Food & beverage: $493
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 13 | $258 |
| Lilly USA, LLC | 4 | $66 |
| Novo Nordisk Inc | 3 | $46 |
| ABBVIE INC. | 1 | $28 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| SK Life Science, Inc. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: KRYSTEXXA, OTEZLA, MOUNJARO, REPATHA, Wegovy, QULIPTA, LEQVIO, GARDASIL 9.
Industry payments across MI — which companies pay providers there.
